A nursing student asks the nurse to differentiate the pathology of Alzheimer's disease from that of Parkinson's disease.
Which description is correct?

Choice A rationale

Working with animals is typically done in preclinical trials before phase I studies in humans and is not part of phase III drug evaluation studies.

Choice B rationale

Conducting research to determine the effectiveness of the drug is part of phase II studies. Phase III studies focus more on confirming effectiveness, monitoring side effects, and comparing it to commonly used treatments.

Choice C rationale

Monitoring and observing patients closely for adverse effects is a key responsibility in phase III drug evaluation studies. These studies involve a larger patient population to gather comprehensive safety and efficacy data.

Choice D rationale

Choosing appropriate patients to be involved in the study is primarily the responsibility of researchers and clinicians during the earlier phases of drug development, such as phase I and phase II studies.

Choice A rationale

Analyzing data collected is part of the assessment phase, not the intervention phase.

Choice B rationale

Collecting a nursing history is part of the assessment phase of the nursing process, not the intervention phase.

Choice C rationale

Determining medication effectiveness is a critical aspect of the intervention phase, as it assesses the therapeutic outcomes of the administered drugs.

Choice D rationale

Documenting the medication is a key action in the intervention phase to ensure accurate and up-to-date patient records and safe administration.

Choice E rationale

Administering the medication is a direct intervention related to drug therapy and is part of the intervention phase.